Back
Beam Therapeutics Vs. Intellia Therapeutics Industry Stock Comparison
Sell
32
BEAM
Beam Therapeutics
Last Price:
26.02
Seasonality Move:
33.43%
Sell
29
NTLA
Intellia Therapeutics
Last Price:
22.92
Seasonality Move:
-1.88%
Sell
32
Beam Therapeutics (BEAM)
is a Sell
Is Beam Therapeutics a Buy, Sell or Hold?
- The current Beam Therapeutics [BEAM] share price is $25.51. The Score for BEAM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- BEAM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $22.52. The Score for NTLA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BEAM Stock Price Chart
What is Beam Therapeutics's stock price today?
-
The Beam Therapeutics share price today is $25.51
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing slight selling pressure.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $22.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.
BEAM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 51.31 | Buy |
| Chaikin Money Flow: | -369164 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.91 - 26.21) | Buy |
| Bollinger Bands (100): | (22.63 - 27.29) | Buy |
NTLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.41 | Sell |
| Relative Strength Index (14 RSI): | 52.84 | Buy |
| Chaikin Money Flow: | -1122879 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.84 - 23.26) | Buy |
| Bollinger Bands (100): | (21.77 - 25.41) | Sell |
BEAM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.83 | Buy |
| 20-day SMA: | 25.22 | Buy |
| 50-day SMA: | 26.27 | Sell |
| 200-day SMA: | 27.35 | Sell |
| 8-day EMA: | 25.17 | Buy |
| 20-day EMA: | 25.17 | Buy |
| 50-day EMA: | 25.51 | Buy |
| 200-day EMA: | 26.94 | Sell |
NTLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.19 | Buy |
| 20-day SMA: | 21.88 | Buy |
| 50-day SMA: | 23.39 | Sell |
| 200-day SMA: | 25.55 | Sell |
| 8-day EMA: | 21.69 | Buy |
| 20-day EMA: | 21.84 | Buy |
| 50-day EMA: | 22.71 | Sell |
| 200-day EMA: | 26.09 | Sell |
Beam Therapeutics Earnings Growth & BEAM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.46 per share, and an increase next year of $0.07 per share.
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.20 per share.
Beam Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Intellia Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||